ClinVar Miner

Submissions for variant NM_173560.4(RFX6):c.2399G>C (p.Gly800Ala)

gnomAD frequency: 0.00225  dbSNP: rs138343620
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Personalized Diabetes Medicine Program, University of Maryland School of Medicine RCV001174497 SCV001337636 likely benign Monogenic diabetes 2018-06-29 criteria provided, single submitter research ACMG criteria: BP4 (5 predictors + REVEL score 0.148; (3 predictors for PP3), BS2 (1 homozygotes in gnomAD; 18 cases and 21 controls in type2diabetesgenetics.org), not using BS1 (1% in 1000G African population but 0.7% in gnomAD African population) = likely benign
Labcorp Genetics (formerly Invitae), Labcorp RCV001579507 SCV002389935 benign not provided 2023-12-01 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV003117803 SCV003799924 likely benign Hypoplastic pancreas-intestinal atresia-hypoplastic gallbalder syndrome 2023-11-29 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV001579507 SCV005225191 likely benign not provided criteria provided, single submitter not provided
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV001579507 SCV001970907 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.